Sociodemographic Factors Influence Use of Proton Pump Inhibitors Among Users of Nonsteroidal Anti-Inflammatory Drugs

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 8, 2009, Pages 855-861

  van Boxel, Ofke S ^a   Hagenaars, Matthijs P ^b   Smout, André J P M ^a   Siersema, Peter D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Achmea Health Insurance ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROTEC; CYCLOOXYGENASE 2 INHIBITOR; ESOMEPRAZOLE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; DEMOGRAPHY; DRUG USE; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; MALE; PHYSICIAN; PRESCRIPTION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT INDICATION; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67949093000     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.05.017     Document Type: Article

References (39)

1. Wolfe M.M., Lichtenstein D.R., and Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340 (1999) 1888-1899
2. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120 (2001) 594-606
3. Gabriel S.E., Jaakkimainen L., and Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115 (1991) 787-796
4. Hernandez-Diaz S., and Rodriguez L.A. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 160 (2000) 2093-2099
5. Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 6 (1996) 489-504
6. Brooks P., Emery P., Evans J.F., et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) 38 (1999) 779-788
7. Dutch Institute for Healthcare Improvement (CBO). Richtlijn NSAID-gebruiken preventie van maagschade. http://www.cbo.nl/product/richtlijnen/folder20021023121843/richtlijnnsaid.pdf/view Accessed December 1, 2008
8. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum 59 (2008) 1058-1073
9. Nederlands Huisartsen Genootschap. NHG standaard Maagklachten. nhg.artsennet.nl/upload/104/standaarden/M36/start.htm Accessed December 1, 2008
10. Smalley W., Stein C.M., Arbogast P.G., et al. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 46 (2002) 2195-2200
11. Abraham N.S., El-Serag H.B., Johnson M.L., et al. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 129 (2005) 1171-1178
12. Pilotto A., Franceschi M., Leandro G., et al. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 20 (2003) 701-710
13. Sturkenboom M.C., Burke T.A., Dieleman J.P., et al. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 42 Suppl 3 (2003) iii23-iii31
14. Thompson P.W., Tee L., McBride J., et al. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Rheumatology (Oxford) 44 (2005) 1308-1310
15. Pilotto A., Franceschi M., Leandro G., et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 20 (2004) 1091-1097
16. Sturkenboom M.C., Burke T.A., Tangelder M.J., et al. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 18 (2003) 1137-1147
17. Knottnerus J.A., and ten Velden G.H. Dutch doctors and their patients--effects of health care reform in the Netherlands. N Engl J Med 357 (2007) 2424-2426
18. Enthoven A.C. Going Dutch-managed-competition health insurance in the Netherlands. van d, V. N Engl J Med 357 (2007) 2421-2423
19. World Health Organization. ATC/DDD Index 2009. www.whocc.no/atcddd/ Accessed January 20, 2009
20. Laine L., Bombardier C., Hawkey C.J., et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 123 (2002) 1006-1012
21. van W.C., Mamdani M.M., Wells P.S., et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323 (2001) 655-658
22. Dalton S.O., Johansen C., Mellemkjaer L., et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163 (2003) 59-64
23. Mellemkjaer L., Blot W.J., Sorensen H.T., et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 53 (2002) 173-181
24. Singh G., and Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl 56 (1999) 18-24
25. Henry D., Dobson A., and Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 105 (1993) 1078-1088
26. Weil J., Langman M.J., Wainwright P., et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 46 (2000) 27-31
27. Van der Heyden J.H., Demarest S., Tafforeau J., et al. Socio-economic differences in the utilisation of health services in Belgium. Health Policy 65 (2003) 153-165
28. Berthold H.K., Gouni-Berthold I., Bestehorn K.P., et al. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med 264 (2008) 340-350
29. van Boxel O.S., Hagenaars M.P., Smout A.J., et al. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther 29 (2009) 571-579
30. Centraal Bureau voor de Statistiek. Kerncijfers postcodegebieden 2004. http://www.cbs.nl/nlNL/menu/themas/dossiers/nederland-regionaal/cijfers/incidenteel/maatwerk/kerncijfers-postcodegebieden-2004.htm Accessed December 1, 2008
31. Nederlands Instituut voor onderzoek van de gezondheidszorg. Herijking achterstandsgebieden. www.nivel.nl/pdf/Rapport-Herijking-achterstandsgebieden-2008.pdf Accessed February 10, 2009
32. Moore R.A., Derry S., Phillips C.J., et al. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. BMC Musculoskelet Disord 7 (2006) 79
33. Kulu-Glasgow I., Delnoij D., and de Bakker D. Self-referral in a gatekeeping system: patients' reasons for skipping the general-practitioner. Health Policy 45 (1998) 221-238
34. Rijks Instituut voor Volksgezondheid en Milieu. Zorg in de grote Steden. http://www.rivm.nl/bibliotheek/rapporten/270556007.pdf Accessed January 15, 2009
35. Meeuwesen L., Harmsen J.A., Bernsen R.M., et al. Do Dutch doctors communicate differently with immigrant patients than with Dutch patients?. Soc Sci Med 63 (2006) 2407-2417
36. Lagro-Janssen A.L. Medicine is not gender-neutral: influence of physician sex on medical care. [in Dutch]. Ned Tijdschr Geneeskd 152 (2008) 1141-1145
37. Eggen A.E. Pattern of drug use in a general population-prevalence and predicting factors: the Tromso study. Int J Epidemiol 23 (1994) 1262-1272
38. Garcia Rodriguez L.A., and Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994) 769-772
39. MacDonald T.M., Morant S.V., Robinson G.C., et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 315 (1997) 1333-1337